Antibiotice gains ground on cardiovascular segment - Azi
All news
The cardiovascular segment was the company"s best performing amid a 4% decline for anti-infective drugs (which include antibiotics). The cardiovascular drugs market, which reached 1.2 billion RON last year (366.5 million euros), is the most valuable market in the pharmaceutical industry and one of the most competitive, given that the...
Read the whole story in: Ziarul Financiar
Contact
Facebook
Twitter
RSS


